| An ethical framework for global vaccine allocation EJ Emanuel, G Persad, A Kern, A Buchanan, C Fabre, D Halliday, J Heath, ... Science 369 (6509), 1309-1312, 2020 | 370 | 2020 |
| Conflicts of interest for patient-advocacy organizations MS McCoy, M Carniol, K Chockley, JW Urwin, EJ Emanuel, H Schmidt New England Journal of Medicine 376 (9), 880-885, 2017 | 199 | 2017 |
| Covax must go beyond proportional allocation of covid vaccines to ensure fair and equitable access LM Herzog, OF Norheim, EJ Emanuel, MS McCoy bmj 372, 2021 | 101 | 2021 |
| Why there are no “potential” conflicts of interest MS McCoy, EJ Emanuel JAMA 317 (17), 1721-1722, 2017 | 90 | 2017 |
| Ethical advocacy across the autism spectrum: Beyond partial representation MS McCoy, EY Liu, ASF Lutz, D Sisti The American Journal of Bioethics 20 (4), 13-24, 2020 | 75 | 2020 |
| Patient and public involvement: two sides of the same coin or different coins altogether? MS McCoy, J Warsh, L Rand, M Parker, M Sheehan Bioethics 33 (6), 708-715, 2019 | 48 | 2019 |
| What are the obligations of pharmaceutical companies in a global health emergency? EJ Emanuel, A Buchanan, SY Chan, C Fabre, D Halliday, J Heath, ... The Lancet 398 (10304), 1015-1020, 2021 | 40 | 2021 |
| National Standards for Public Involvement in Research: missing the forest for the trees MS McCoy, KR Jongsma, P Friesen, M Dunn, CP Neuhaus, L Rand, ... Journal of Medical Ethics 44 (12), 801-804, 2018 | 39 | 2018 |
| Patient‐engaged research: Choosing the “right” patients to avoid pitfalls EA Largent, HF Lynch, MS McCoy Hastings Center Report 48 (5), 26-34, 2018 | 31 | 2018 |
| Sharing patient data without exploiting patients MS McCoy, S Joffe, EJ Emanuel Jama 323 (6), 505-506, 2020 | 30 | 2020 |
| Ethical responsibilities for companies that process personal data MS McCoy, AL Allen, K Kopp, MM Mello, DJ Patil, P Ossorio, S Joffe, ... The American Journal of Bioethics 23 (11), 11-23, 2023 | 29 | 2023 |
| Ten years later: a review of the US 2009 institute of medicine report on conflicts of interest and solutions for further reform T Torgerson, C Wayant, L Cosgrove, EA Akl, J Checketts, R Dal Re, J Gill, ... BMJ evidence-based medicine 27 (1), 46-54, 2022 | 29 | 2022 |
| What does it mean to engage the public in the response to covid-19? N Scheinerman, M McCoy bmj 373, 2021 | 24 | 2021 |
| Public involvement in the governance of population-level biomedical research: Unresolved questions and future directions S Erikainen, P Friesen, L Rand, K Jongsma, M Dunn, A Sorbie, M McCoy, ... Journal of Medical Ethics, 2020 | 24 | 2020 |
| Conflicts of interest of public speakers at meetings of the Anesthetic and Analgesic Drug Products Advisory Committee MS McCoy, O Pagán, G Donohoe, GP Kanter, RS Litman JAMA internal medicine 178 (7), 996-997, 2018 | 23 | 2018 |
| On the ethics of vaccine nationalism: the case for the fair priority for residents framework EJ Emanuel, A Buchanan, SY Chan, C Fabre, D Halliday, RJ Leland, ... Ethics & international affairs 35 (4), 543-562, 2021 | 22 | 2021 |
| Industry support of patient advocacy organizations: the case for an extension of the sunshine act provisions of the affordable care act MS McCoy American journal of public health 108 (8), 1026-1030, 2018 | 22 | 2018 |
| Prevalence of Third-Party Tracking on COVID-19–Related Web Pages MS McCoy, T Libert, D Buckler, DT Grande, AB Friedman JAMA, 2020 | 19 | 2020 |
| Prevalence of third-party tracking on abortion clinic web pages AB Friedman, L Bauer, R Gonzales, MS McCoy JAMA Internal Medicine 182 (11), 1221-1222, 2022 | 16 | 2022 |
| The limits of acceptable political influence over the FDA H Fernandez Lynch, S Joffe, MS McCoy Nature medicine 27 (2), 188-190, 2021 | 13 | 2021 |
